Literature DB >> 10777055

In vitro proliferation and in vivo malignancy of cell lines simultaneously derived from a chemically-induced heterogeneous rat mammary tumor.

F Tagliaferri1, L Teodori, M G Valente, F Stipa, A Cucina, W Göhde, D Colettii, P Alo, S Stipa.   

Abstract

Identification of clones in primary tumors responsible for proliferation, invasion, and metastasis was carried out. Four different aneuploid established cell lines derived from a ductal infiltrating mammary rat tumor induced by 7,12-dimethylbenz[a]anthracene were studied for proliferative and growth features in vitro and for tumorigenic and metastatic potential in vivo in nude mice. Clones, named RM1, RM2, RM3, and RM4, were characterized by different proliferative activity. Clone RM1 showed the highest proliferative activity by both tritiated thymidine incorporation and S-phase flow cytometry, followed by clone RM4. Conversely, clones RM2 and RM3 showed a lower proliferation rate. Growth-promoting activity, tested on 3T3 Swiss cells, was high in all clones, although RM1 showed significantly lower growth factors-releasing activity. Nude mice tumorigenesis demonstrated a strong tumor induction of line RM1 (100% of the mice after 47 +/- 7 d) and a slightly lower tumor induction of line RM4 (70% of the mice after 69 +/- 9 d). Line RM3 showed tumor induction in 40% of the mice after 186 +/- 16 d. Lines RM2 showed no tumor induction. Metastasis occurred in mice treated with line RM1 only. Therefore, tumorigenesis and metastasis correlate with proliferation but not with the release of growth factors. In conclusion, flow cytometry monitoring of clones from heterogeneous primary tumors proved to be a suitable model for the study of in vivo malignancy and in vitro proliferation.

Entities:  

Mesh:

Year:  2000        PMID: 10777055     DOI: 10.1290/1071-2690(2000)036<0163:ivpaiv>2.0.co;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  17 in total

Review 1.  Animal care and use: an issue now and in the future.

Authors:  A F Kertz
Journal:  J Anim Sci       Date:  1996-01       Impact factor: 3.159

Review 2.  Stimulation of DNA synthesis in quiescent cultured cells: exogenous agents, internal signals, and early events.

Authors:  E Rozengurt
Journal:  Curr Top Cell Regul       Date:  1980

3.  Flow cytometric and molecular analysis of proliferative activity and DNA content in neuroblastoma: presence of stationary cells in S-phase.

Authors:  C Dominici; A Negroni; A Romeo; H McDowell; A Padula; S Pucci; C Cappelli; M A Castello; G Raschellà
Journal:  Anticancer Res       Date:  1992 Jan-Feb       Impact factor: 2.480

Review 4.  Desmosomes and cancer.

Authors:  D R Garrod
Journal:  Cancer Surv       Date:  1995

5.  Coexpression of alpha-sarcomeric actin, alpha-smooth muscle actin and desmin during myogenesis in rat and mouse embryos I. Skeletal muscle.

Authors:  F Babai; J Musevi-Aghdam; W Schurch; A Royal; G Gabbiani
Journal:  Differentiation       Date:  1990-08       Impact factor: 3.880

6.  Trisomy 1 and 8 occur frequently in hepatocellular carcinoma but not in liver cell adenoma and focal nodular hyperplasia. A fluorescence in situ hybridization study.

Authors:  A Nasarek; M Werner; M Nolte; J Klempnauer; A Georgii
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

7.  Rat myoblastic sarcoma cell lines. A model for the study of invasion, metastasis, and myogenic differentiation.

Authors:  F Babaï; A Royal
Journal:  Lab Invest       Date:  1994-06       Impact factor: 5.662

8.  Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor.

Authors:  D I Kleinerman; P Troncoso; S H Lin; L L Pisters; E R Sherwood; T Brooks; A C von Eschenbach; J T Hsieh
Journal:  Cancer Res       Date:  1995-03-15       Impact factor: 12.701

Review 9.  Experimentally induced mammary tumors in rats.

Authors:  J Russo; I H Russo
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

10.  Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

Authors:  M S O'Reilly; L Holmgren; Y Shing; C Chen; R A Rosenthal; M Moses; W S Lane; Y Cao; E H Sage; J Folkman
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.